National Jan 21, 2022
Japan approves Pfizer shot for children age 5 to 11 as omicron spreads
by Osamu Tsukimori
The health ministry has issued fast-track approval to ease the age restriction on receiving the Pfizer vaccine.
World / Science & Health Jan 16, 2022
The decades of discoveries before the ‘miraculous’ sprint to a vaccine
by Gina Kolata and Benjamin Mueller
The breakthroughs behind the vaccines unfolded over decades, little by little, as scientists across the world pursued research in disparate areas.
National Jan 14, 2022
The country has already agreeing to procure enough of the drug, Paxlovid, for 2 million people
World / Science & Health Jan 11, 2022
Pfizer starts making vaccine that targets both omicron and the original COVID virus
by Riley Griffin
While research continues, Pfizer will evaluate the new hybrid shot against one specific to omicron and determine which should move forward by March, the firm's CEO has said.
National | EXPLAINER Jan 6, 2022
The ins and outs of Japan's COVID-19 booster shot rollout
by Osamu Tsukimori
Japan recommends people receive a different shot for their third doses to the one they received in the initial rollout, but what's the rationale behind that strategy?
World / Science & Health Dec 18, 2021
Pfizer says pandemic could extend through 2023, studies three-dose vaccine course for children
Pfizer executives said the company believed that by 2024, the disease should be endemic around the globe, meaning it would no longer be a pandemic.
National Dec 17, 2021
Kishida asks Pfizer to expedite supply of further vaccines to Japan
Japan is looking to move up the third round of shots by revising the planned eight-month interval between second jabs and boosters.
Business Dec 17, 2021
Pfizer will dominate $20 billion COVID-19 pill market in 2022, analysis shows
by James Paton
Demand for the medications is poised to outpace supply as COVID-19 spreads around the globe and scientists question how well vaccines and antibody treatments will hold up against omicron.
World Dec 15, 2021
Pfizer says COVID-19 pill near 90% protective against hospitalization and death
Recent lab data suggests the drug retains its effectiveness against the fast spreading omicron variant of the coronavirus.
Business Dec 13, 2021
Billionaire’s bet on Pfizer vaccine for China fails to pay off
Xi Jinping’s administration has backed a nationalist agenda on all fronts, including in the fight against the virus.
National Dec 9, 2021
Japan in talks with Pfizer about expedited booster shot delivery
Japan is due to receive 120 million doses in 2022 from Pfizer, which said Wednesday a third shot of its vaccine appears to offer sufficient protection against the omicron variant.
World / Science & Health Dec 9, 2021
A lab test indicated that three doses of the Pfizer-BioNTech coronavirus vaccine will be effective against the omicron variant.